Viatris price target lowered to $9 from $12 at Barclays

Barclays analyst Balaji Prasad lowered the firm’s price target on Viatris (VTRS) to $9 from $12 and keeps an Underweight rating on the shares. The stock fell 15% on the Indore Facility impacting the 2025 outlook, the analyst tells investors in a research note. The firm says the path for stock recovery is challenging until this is resolved.